ProjectGPR85 agonists – Unlocking the hidden potential of the orphan receptor GPR85 as a novel therapeutic target:…

Basic data

Acronym:
GPR85 agonists
Title:
Unlocking the hidden potential of the orphan receptor GPR85 as a novel therapeutic target: Finding lead compounds, structure-activity relationship study and pharmacological evaluation
Duration:
01/01/2025 to 31/12/2028
Abstract / short description:
Receptors present in the brain such as G protein coupled receptors (GPCR) are instrumental to
normal human cognitive processes. Their dysfunction, induced notably by perturbed signalling
process, may contribute to a wide variety of neurodegenerative diseases or mental disorders. For
instance, dopamine and glutamate systems, notably in the hippocampus, are thought to
contribute to the pathogenesis of psychosis such as schizophrenia, a debilitating condition
characterised by abnormal behaviour, disconnection from reality, delusions and hallucinations.1,2
The pathophysiology of this disease is not well understood but increasing evidence points to
genetic mutations associated with phenotypic perturbations, mainly in the dopamine and
glutamate networks.3 Current antipsychotics treatments based on dopamine receptor D2
antagonists suffer from important drawbacks and severe side effects. The important unmet
medical need in this area warrants research efforts to identify novel receptors that could affect
brain function and play a role in schizophrenia

Involved staff

Managers

Pharmaceutical Institute
Department of Pharmacy and Biochemistry, Faculty of Science

Local organizational units

Department of Pharmacy and Biochemistry
Faculty of Science
University of Tübingen

Funders

Bonn, Nordrhein-Westfalen, Germany
Help

will be deleted permanently. This cannot be undone.